Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Nanovibronix Inc (NQ: NAOV )

0.7220 +0.0020 (+0.28%)
Streaming Delayed Price Updated: 2:31 PM EDT, May 15, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 13,048
Open 0.7500
Bid (Size) 0.7200 (1)
Ask (Size) 0.7450 (12)
Prev. Close 0.7200
Today's Range 0.7100 - 0.7500
52wk Range 0.6775 - 4.230
Shares Outstanding 2,784,354
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
NanoVibronix Announces Distribution Agreement with VA Supplier CB Medical for the Distribution of UroShield
From NanoVibronix, Inc.
Via Business Wire
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga

Performance

YTD
-37.22%
-37.22%
1 Month
-9.75%
-9.75%
3 Month
-43.19%
-43.19%
6 Month
-30.98%
-30.98%
1 Year
-80.18%
-80.18%

More News

Read More
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
Why Apple Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket
Via Benzinga
NAOV Stock Earnings: NanoVibronix Reported Results for Q4 2023
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
NanoVibronix Announces PainShield Will Be Included in Department of Veteran Affairs’ FSS Contract Award
From NanoVibronix, Inc.
Via Business Wire
NanoVibronix Issues Letter to Stockholders
From NanoVibronix, Inc.
Via Business Wire
NanoVibronix Signs Agreement for Research and Development of Next Generation PainShield and UroShield
From NanoVibronix, Inc.
Via Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
NanoVibronix Featured in Your Bladder Health Magazine
From NanoVibronix, Inc.
Via Business Wire
NanoVibronix Enters into Letter of Intent with APOGEPHA Arzneimittel GmbH to Explore European Distribution Opportunity
From NanoVibronix, Inc.
Via Business Wire
NanoVibronix Announces Agreement for Clinical Study of UroShield at the University of Michigan
From NanoVibronix, Inc.
Via Business Wire
NanoVibronix Regains Nasdaq Compliance
From NanoVibronix, Inc.
Via Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
NanoVibronix Issues Letter to Shareholders
From NanoVibronix, Inc.
Via Business Wire
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
NanoVibronix UroShield Products Available on NHS Drug Tariff Effective November 1
From NanoVibronix, Inc.
Via Business Wire
Why Streamline Health Solutions Shares Are Trading Lower By Over 68%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
NanoVibronix Gains Approval for Inclusion of UroShield Products in NHS Prescription Services’ Drug Tariff
From NanoVibronix, Inc.
Via Business Wire
BioMedNewsBreaks – IBN’s BioMedWire Highlights NanoVibronix Inc.’s (NASDAQ: NAOV) $5M Private Placement
Via Investor Brand Network
NanoVibronix Announces Presentation of Positive Independent Testing Results of UroShield at ICS Annual Meeting
From NanoVibronix, Inc.
Via Business Wire
NanoVibronix Announces $5 Million Private Placement Priced At-The-Market Under Nasdaq Rules
From NanoVibronix, Inc.
Via Business Wire
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.